A new study uncovers vulnerabilities in drug-resistant TB, offering hope for improved treatments.
First participant vaccinated in study of ovx836 booster dose
Therapy shows high efficacy in initial trial phase
Anti-epileptic drugs and cardiovascular eventsData from nearly 30 000 participants in a Canadian longitudinal study of ageing suggest […]
If the NHS is broken, as the UK health secretary, Wes Streeting, says,1 better use of data should […]
Updated Date: Wed, 06 Nov 2024 00:00:00 EST
Updated Date: Wed, 06 Nov 2024 00:00:00 EST
bmj;387/nov12_10/q2481/FAF1faJulia and Malcolm Donaldsondonaldson20241111.f1Malcolm Donaldson was a distinguished paediatric endocrinologist with a string of research publications to his […]
Terminally ill adults in England and Wales who are expected to die within six months would be able […]
First patient dosed in phase 1b trial of MB310 therapy